View in EDS

Orphan drug clinical development.

Saved in:
Bibliographic Details
Title: Orphan drug clinical development.
Authors: Blin O; Service de pharmacologie clinique et pharmacovigilance, Aix Marseille Univ, AP-HM, INSERM, Inst Neurosci Syst, 13005 Marseille, France; Orphandev-FCRIN, INSERM, 13005 Marseille, France. Electronic address: olivier.blin@ap-hm.fr., Lefebvre MN; Service de pharmacologie clinique et pharmacovigilance, Aix Marseille Univ, AP-HM, INSERM, Inst Neurosci Syst, 13005 Marseille, France; Orphandev-FCRIN, INSERM, 13005 Marseille, France., Rascol O; Services de pharmacologie clinique et neurosciences, centre d'investigation clinique CIC 1436, NS-Park/FCRIN network, NeuroToul COEN center, université de Toulouse UPS, CHU de Toulouse, INSERM, 31000 Toulouse, France., Micallef J; Service de pharmacologie clinique et pharmacovigilance, Aix Marseille Univ, AP-HM, INSERM, Inst Neurosci Syst, 13005 Marseille, France.
Source: Therapie [Therapie] 2020 Apr; Vol. 75 (2), pp. 141-147. Date of Electronic Publication: 2020 Feb 13.
Publication Type: Journal Article; Review
Journal Info: Publisher: Elsevier Masson Country of Publication: France NLM ID: 0420544 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1958-5578 (Electronic) Linking ISSN: 00405957 NLM ISO Abbreviation: Therapie Subsets: MEDLINE
Database: MEDLINE Ultimate
Description
ISSN:1958-5578
DOI:10.1016/j.therap.2020.02.004